Oxytocin Effect on Attention Inhibition

NCT03486925 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2019-03-04

No results posted yet for this study

Summary

Effects of intranasal oxytocin (24IU) on cognitive control of attention

Conditions

  • Healthy

Interventions

DRUG

oxytocin treatment

intranasal administration of oxytocin (24IU)

DRUG

placebo treatment

intranasal administration of placebo

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-19
Primary Completion
2018-07-20
Completion
2018-08-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03486925 on ClinicalTrials.gov